A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndromeOliver Groß, Markus Feldkoetter, Kay Latta et al.|Kidney International|2020Cited by 151
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal functionMathilda Bedin, Matias Simons, Olivia Boyer et al.|Journal of Clinical Investigation|2019Cited by 104